---
title: Pegylated interferon-α2a in cutaneous T-cell lymphoma - a multicenter retrospective
  data analysis with 70 patients
date: '2024-10-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39358932/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241003195209&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Our analysis provides comprehensive data on the efficacy
  and tolerability of pegIFNα-2a therapy in patients with CTCL. In terms of response
  rates and side effect profile, pegIFNα-2a appears to be comparable to IFN-α2a ...'
disable_comments: true
---
CONCLUSIONS: Our analysis provides comprehensive data on the efficacy and tolerability of pegIFNα-2a therapy in patients with CTCL. In terms of response rates and side effect profile, pegIFNα-2a appears to be comparable to IFN-α2a ...